InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (14 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
14
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Riggs Rory B. Insider active across 4 companies, notably Royalty Pharma plc. Aggregated, 54 disclosures have been logged. Split: 0 buy · 14 sells. Total volume traded: €92.4m. Activity tracked since 7 May 2021. The latest transaction was disclosed on 29 January 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Riggs Rory B
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations54 total
333,333 shares@ US$1.503.8% of flowClass A Common StockSEC:0001193125-26-034092:0
4,000,000 shares0.0% of flowClass A Common StockSEC:0000950170-25-084928:0
5,714,286 shares@ US$1.7582.7% of flowClass A Common StockSEC:0000950170-25-084320:0
131,512 shares@ US$132.0090.2% of flowCommon StockSEC:0000950170-25-049648:0
1,388,084 sharesClass B Common StockSEC:0001615594-25-000004:0
215 shares@ US$83.520.1% of flowCommon StockSEC:0000950170-25-001440:0
14,189 sharesCommon StockSEC:0000950170-24-114785:0
246 shares@ US$73.170.1% of flowCommon StockSEC:0000950170-24-111766:0
250,000 shares@ US$4.0049.1% of flowClass A Common StockSEC:0000950170-24-108504:0
262 shares@ US$68.490.1% of flowCommon StockSEC:0000950170-24-080986:0
1,567 sharesCommon StockSEC:0000950170-24-077468:0
98,040 shares@ US$10.2050.9% of flowClass A Common StockSEC:0000950170-24-073319:0
260 shares@ US$69.200.1% of flowCommon StockSEC:0000950170-24-040165:0
20,000 shares@ US$18.561.9% of flowCommon StockSEC:0000950170-24-035358:0
300,000 shares0Class A Ordinary SharesSEC:0001802768-24-000014:0
235,200 shares@ US$28.51655.6% of flowClass A Ordinary SharesSEC:0001802768-24-000002:0
1,505,967 shares0Class B Common StockSEC:0000899243-24-000057:0
251 shares@ US$71.620.1% of flowCommon StockSEC:0000950170-24-001305:0
39,476 shares0Class A Common StockSEC:0000950170-23-070459:0
475,590 shares0Class A Ordinary SharesSEC:0001802768-23-000030:0
345 shares@ US$52.090.1% of flowCommon StockSEC:0001209191-23-051140:0
279 shares@ US$63.320.1% of flowCommon StockSEC:0001209191-23-041097:0
7,747 shares0Class A Ordinary SharesSEC:0001209191-23-039694:0
848,662 sharesClass A Common StockSEC:0000899243-23-014329:0
1,750,000 shares@ US$32.8248.7% of flowClass A Ordinary SharesSEC:0001209191-23-031614:0
25 of 54 declarations
About Riggs Rory B
RIGGS RORY B is a Director of Intra-Cellular Therapies, Inc., Royalty Pharma plc, Cibus, Inc. and FIBROGEN INC. He has 54 filings in total, and across the recent filings tracked, the recorded amounts are sell transactions for EUR 108346821, with activity ranging from 2016-01-05 to 2026-02-02; the modal transaction nature is Attribution.
